GCG and graft versus host disease: Teduglutide, a dipeptidyl peptidase inhibitor 4 (DPP4)-resistant analog of GLP-2, protects intestinal stem cells and enhances the barrier effects of the intestinal mucosa in experimental GVHD (106).